1. Collazo CM, Galán JE. Requirement for exported proteins in secretion through the invasion-associated type III system of
Salmonella Typhimurium. Infect Immun. 1996. 64:3524–3531.
Article
2. Darwin KH, Miller VL. Molecular basis of the interaction of
Salmonella with the intestinal mucosa. Clin Microbiol Rev. 1999. 12:405–428.
Article
3. Nógrády N, Gadó I, Tóth A, Pászti J. Antibiotic resistance and class 1 integron patterns of non-typhoidal human
Salmonella serotypes isolated in Hungary in 2002 and 2003. Int J Antimicrob Agents. 2005. 26:126–132.
Article
4. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003. 51:1109–1117.
Article
5. Choi SH, Woo JH, Lee JE, Park SJ, Choo EJ, Kwak YG, et al. Increasing incidence of quinolone resistance in human non-typhoid
Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. J Antimicrob Chemother. 2005. 56:1111–1114.
Article
6. Ball P. Quinolone generations: natural history or natural selection? J Antimicrob Chemother. 2000. 46:17–24.
Article
7. Paton JH, Reeves DS. Fluoroquinolone antibiotics. Microbioloy, pharmacokinetics and clinical use. Drugs. 1988. 36:193–228.
8. Vila J. White DG, Alekshun MN, McDermotte PF, editors. Fluoroquinolone resistance. Frontiers in antimicrobial resistance: a tribute to Stuart B. Levy. 2005. Herndon, VA: ASM Press;41–52.
Article
9. Everett MJ, Jin YF, Ricci V, Piddock LJ. Contributions of individual mechanisms to fluoroquinolone resistance of 36
Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother. 1996. 40:2380–2386.
Article
10. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental
in vitro- and
in vivo-selected mutants of
Salmonella spp. suggest a counterselection of highly fluoroquinolone resistant strains in the field. Antimicrob Agents Chemother. 1999. 43:2131–2137.
Article
11. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC.
Qnr prevalence in ceftazidime-resistant
Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006. 50:2872–2874.
Article
12. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of
aac(6')-Ib-cr encoding a ciprofloxacin modifying enzyme. Antimicrob Agents Chemother. 2006. 50:3953–3955.
Article
13. Kang HY, Tamang MD, Seol SY, Kim JM. Dissemination of plasmid-mediated
qnr,
aac(6)-Ib-cr, and
qepA genes among 16S rRNA methylase producing
Enterobacteriaceae in Korea. J Bacteriol Virol. 2009. 39:173–182.
Article
14. Fàbrega A, Sánchez-Céspedes J, Soto S, Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents. 2008. 31:307–315.
Article
15. Hwang IS, Song JY, Kim WJ, Jeong HW, Kim MS, Cheong HJ. Prevalence and mechanisms of low level quinolone resistance among non-typhoidal
Salmonella isolates from human and poultry/livestock in Korea: usefulness of nalidixic acid resistance test. Infect Chemother. 2010. 42:230–236.
Article
16. Lunn AD, Fàbrega A, Sánchez-Céspedes J, Vila J. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates. Int Microbiol. 2010. 13:15–20.
17. Lee K, Lee M, Lim J, Jung J, Park Y, Lee Y. Contamination of chicken meat with Salmonella enterica serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility. J Microbiol Biotechnol. 2008. 18:1853–1857.
18. Hamidian M, Tajbakhsh M, Tohidpour A, Rahbar M, Zali MR, Walther-Rasmussen J. Detection of novel
gyrA mutations in nalidixic acid-resistant isolates of
Salmonella enterica from patients with diarrhoea. Int J Antimicrob Agents. 2011. 37:360–364.
Article
19. Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, et al. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in
Salmonella isolated from 12 tertiary-care hospitals in Korea. Microb Drug Resist. 2011. 17:551–557.
Article
20. Kim KY, Park JH, Kwak HS, Woo GJ. Characterization of the quinolone resistance mechanism in foodborne
Salmonella isolates with high nalidixic acid resistance. Int J Food Microbiol. 2011. 146:52–56.
Article
21. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs. 1999. 58:Suppl 2. 11–18.
Article
22. Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, et al. Prevalence of mutations within the quinolone resistance-determining region of
gyrA,
gyrB,
parC, and
parE and association with antibiotic resistance in quinolone-resistant
Salmonella enterica. Antimicrob Agents Chemother. 2004. 48:4012–4015.
Article
23. Ling JM, Chan EW, Lam AW, Cheng AF. Mutations in topoisomerase genes of fluoroquinolone-resistant
Salmonellae in Hong Kong. Antimicrob Agents Chemother. 2003. 47:3567–3573.
Article
24. Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance in Gram-nagative bacterial species: an update. Curr Med Chem. 2009. 16:1028–1046.
Article
25. Shin JH, Jung HJ, Lee JY, Kim HR, Lee JN, Chang CL. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant
Escherichia coli and
Klebsiella pneumoniae from urinary tract infections in Korea. Microb Drug Resist. 2008. 14:221–226.
Article
26. Yu F, Chen Q, Yu X, Pan J, Li Q, Yang L, et al. High prevalence of plasmid-mediated quinolone resistance determinant
aac(6')-Ib-cr amongst
Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China. Int J Antimicrob Agent. 2011. 37:152–155.
Article
27. Sjölund-Karlsson M, Folster JP, Pecic G, Joyce K, Medalla F, Rickert R, et al. Emergence of plasmid-mediated quinolone resistance among non-typhi
Salmonella enterica isolates from humans in the United States. Antimicrob Agents Chemother. 2009. 53:2142–2144.
Article
28. Taguchi M, Kawahara R, Seto K, Inoue K, Hayashi A, Yamagata N, et al. Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan. Jpn J Infect Dis. 2009. 62:312–314.